AMA
Konrad P, Chojnacki J, Gąsiorowska A, Rudnicki C, Kaczka A, Chojnacki C. Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection. Gastroenterology Review/Przegląd Gastroenterologiczny. 2018;13(3):213-217. doi:10.5114/pg.2018.74228.
APA
Konrad, P., Chojnacki, J., Gąsiorowska, A., Rudnicki, C., Kaczka, A., & Chojnacki, C. (2018). Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection. Gastroenterology Review/Przegląd Gastroenterologiczny, 13(3), 213-217. https://doi.org/10.5114/pg.2018.74228
Chicago
Konrad, Paulina, Jan Chojnacki, Anita Gąsiorowska, Cezary Rudnicki, Aleksandra Kaczka, and Cezary Chojnacki. 2018. "Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection". Gastroenterology Review/Przegląd Gastroenterologiczny 13 (3): 213-217. doi:10.5114/pg.2018.74228.
Harvard
Konrad, P., Chojnacki, J., Gąsiorowska, A., Rudnicki, C., Kaczka, A., and Chojnacki, C. (2018). Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection. Gastroenterology Review/Przegląd Gastroenterologiczny, 13(3), pp.213-217. https://doi.org/10.5114/pg.2018.74228
MLA
Konrad, Paulina et al. "Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 13, no. 3, 2018, pp. 213-217. doi:10.5114/pg.2018.74228.
Vancouver
Konrad P, Chojnacki J, Gąsiorowska A, Rudnicki C, Kaczka A, Chojnacki C. Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection. Gastroenterology Review/Przegląd Gastroenterologiczny. 2018;13(3):213-217. doi:10.5114/pg.2018.74228.
